AB0760 Role of oral cyclophosphamide in the treatment of giant cell arteritis

Background Glucocorticoids (GC)-related adverse events greatly contribute to the outcome in giant cell arteritis (GCA). There is limited evidence of the efficacy of some DMARDs as steroid-sparing agents in GCA. CYC may be of value in the treatment of systemic vasculitis, including large vessel arter...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.682-682
Hauptverfasser:	Quartuccio, L., Maset, M., De Maglio, G., Pontarini, E., Fabris, M., Mariuzzi, L., Pizzolitto, S., Beltrami, C.A., De Vita, S.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!